Daisuke Watanabe

Dr. Daisuke Watanabe

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in The Aging Male
Verified
Journal Article
Closed access
DWDaisuke Watanabe
Daisuke Watanabe
AYAkemi Yamashita
Akemi Yamashita
KMKunihisa Miura
Kunihisa Miura
AMAkio Mizushima
Akio Mizushima
This study investigated what sort of effects would occur in terms of sexual function in Japanese patients with benign prostatic hyperplasia (BPH), upon switching from combination therapy with an alpha 1 blocker (AB) and dutasteride (DUT) to combination therapy with tadalafil (TAD) and DUT. The baseline and the 15-item International Index of Erectile Function (IIEF-15), Erection Hardness Score (EHS), International Prostate Symptom Score (IPSS), and Overactive Bladder Symptom Score (OABSS) 3 months after switching to the daily administration of TAD 5 mg/DUT 0.5 mg combination therapy, along with the age, prostatic volume, body mass index (BMI), and past medical history of 49 patients who were treated with AB/DUT as pretreatment, were retrospectively investigated. TAD/DUT combination therapy significantly improved the total score of IIEF-15 (from 17.8 +/- 11.6 to 21.4 +/- 13.9, p = .0047), erectile function domain (from 5.8 +/- 5.8 to 7.6 +/- 7.1, p = .0186), and EHS (from 1.9 +/- 1.3 to 2.6 +/- 1.2, p < .0001). Although IPSS and QOL index were significantly improved, no significant differences were observed for OABSS. Switching from AB/DUT combination therapy to TAD/DUT combination therapy brought about improvement in erectile function while leaving room to improve urinary status in Japanese patients.

20 January 2020 in The Aging Male
Verified
Journal Article
Closed access
DWDaisuke Watanabe
Daisuke Watanabe
TKTakahiro Kimura
Takahiro Kimura
AYAkemi Yamashita
Akemi Yamashita
TMTadaaki Minowa
Tadaaki Minowa
KMKunihisa Miura
Kunihisa Miura
AMAkio Mizushima
Akio Mizushima
The influence of androgen deprivation therapy (ADT) for prostate cancer on the hip geometric properties evaluated by dual-energy X-ray absorptiometry (DXA) has not yet been demonstrated. This study aimed to investigate the changes in these properties after 1 year of ADT. A total of 65 Japanese men with prostate cancer who underwent ADT for the first time in our facility were included in the study. The hip geometric parameters and the bone mineral density (BMD) taken before and after 1 year of ADT were retrospectively examined. With ADT, we not only confirmed significant BMD annual changes in the lumbar spine, the femoral neck, and the total hip of −1.65%, −1.91%, and −2.20%, respectively, but we also confirmed significant annual changes in cross-sectional areas, cross-sectional moments of inertia, and section modulus in the narrow femoral neck of −2.55%, −3.50%, and −3.14%, respectively. The annual rate of decrease in the femoral neck BMD was significantly higher in patients with visceral fat obesity than in those without visceral obesity (−1.79% vs. −0.28%). One year of ADT for Japanese men with prostate cancer might decrease the strength of bending and the structural rigidity as well as BMD at the femoral neck.

16 November 2020 in The Aging Male
Verified
Journal Article
Closed access
DWDaisuke Watanabe
Daisuke Watanabe
HTHiromitsu Takano
Hiromitsu Takano
TKTakahiro Kimura
Takahiro Kimura
AYAkemi Yamashita
Akemi Yamashita
TMTadaaki Minowa
Tadaaki Minowa
AMAkio Mizushima
Akio Mizushima
The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in prostate cancer patients and its relationship with prevalent vertebral fractures (PVF) has not yet been demonstrated. This study aimed to investigate the relationship of DISH, visceral fat accumulation, and other age-related diseases to PVF in elderly men with castration-naïve prostate cancer (CNPC). A total of 134 CNPC patients who were ≥65 years of age without bone metastases were registered in this study. DISH was found in 36.6% (49/134) of the patients in the study population. Patients with DISH were significantly older and had a lower total hip-bone mineral density (BMD) than those without DISH. On the other hand, there were no significant differences in fat distribution, prevalence of hypertension, dyslipidemia, diabetes, fasting plasma glucose (FPG), hemoglobin A1c (HbA1c, prostate-specific antigen (PSA), or lumbar-BMD (L-BMD). A multivariate analysis of age, DISH, body mass index (BMI), visceral fat area (VFA), and total hip-BMD, which were significantly associated with PVF in a univariate analysis, showed that age (OR 1.11; p = .02) and DISH (OR 5.99; p = .0003) were independently associated with PVF. This study suggests that the presence of DISH may not be negligible when assessing the risk of vertebral fracture in prostate cancer patients before treatment.

Verified
Journal Article
Open access
PDF file
KYKazuki Yanagida
Kazuki Yanagida
DWDaisuke Watanabe
Daisuke Watanabe
TYTakahiro Yoshida
Takahiro Yoshida
AMAkio MIZUSHIMA
Akio MIZUSHIMA
TNTohru Nakagawa
Tohru Nakagawa
Background: The effect of combining an α1-adrenergic receptor blocker (α1-blocker) and the β3-adrenoceptor agonist vibegron for treating persistent overactive bladder (OAB) symptoms associated with benign prostatic hyperplasia (BPH) on sexual function remains uncertain. Therefore, we aimed to evaluate the effects of vibegron as an add-on to α1-blocker therapy on both OAB and sexual function. Methods: Forty-three patients with BPH in whom OAB symptoms were inadequately controlled by α1-blocker treatment were included in this prospective open-label study. The OAB Symptom Score (OABSS), International Prostate Symptom Score (IPSS), 15-item International Index of Erectile Function (IIEF-15), and Erection Hardness Score (EHS), as well as the residual urine volume and serum-free testosterone (FT) and C-reactive protein (CRP) levels, were evaluated before and 8 weeks after the daily administration of 50 mg vibegron/α1-blocker combination therapy. Results: Vibegron/α1-blocker combination therapy significantly improved the OABSS (from 6.9 ± 2.6 to 5.1 ± 2.9, p < 0.0001) and IIEF intercourse satisfaction domain (from 1.1 ± 2.3 to 1.9 ± 2.6, p = 0.02). No significant differences were observed for the IPSS, EHS, total IIEF-15 score, residual urine volume, and serum FT and CRP levels. Conclusions: The study findings suggest that vibegron/α1-blocker combination therapy improves OAB and sexual satisfaction.

17 September 2021 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
DWDaisuke Watanabe
Daisuke Watanabe
KMKunihisa Miura
Kunihisa Miura
AYAkemi Yamashita
Akemi Yamashita
TMTadaaki Minowa
Tadaaki Minowa
YUYuko Uehara
Yuko Uehara
AMAkio Mizushima
Akio Mizushima
Background: The geriatric nutritional risk index (GNRI) is reportedly a useful factor for predicting postoperative complications in elderly patients with several cancers. The aim of this study was to investigate the relationship between postoperative complications and the GNRI in elderly patients with renal cell carcinoma (RCC). Materials and Methods: The clinical data of 62 patients who were >= 65 years old and underwent open surgery for RCC were analyzed retrospectively. The American Society of Anesthesiologists physical status, Charlson comorbidity index, surgical procedure, body mass index, GNRI, platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio (NLR), psoas muscle index (PMI), visceral fat area, and subcutaneous fat area were examined. The association of the GNRI and immunonutritional parameters with postoperative complications was analyzed by the univariate and multivariate analyses. Results: Grade >= II postoperative complications evaluated by the Clavien-Dindo classification were seen in 11 out of 62 cases. In the Spearman's correlation test, the GNRI showed a significant negative correlation with the PLR and NLR and a significant positive correlation with the PMI. The group with postoperative complications showed a significantly lower GNRI, higher PLR, and higher NLR than those without complications. In the multivariate analysis, a GNRI <= 92 was independently associated with postoperative complications. Conclusion: The GNRI might play an important role in evaluation of the risk of postoperative complications in open surgery for elderly RCC patients.

23 August 2022 in The Aging Male
Verified
Journal Article
Open access
DWDaisuke Watanabe
Daisuke Watanabe
TKTakahiro Kimura
Takahiro Kimura
KYKazuki Yanagida
Kazuki Yanagida
TYTakahiro Yoshida
Takahiro Yoshida
NKNorikazu Kawae
Norikazu Kawae
AMAkio Mizushima
Akio Mizushima
Osteoporosis is often accompanied by bone loss with fat accumulation of the red marrow. A novel technique for quantification of iron and fat content by MRI IDEAL-IQ can visualize hematopoietic areas and fatty deposits in bone marrow; however, the relationship between these indices and total hip bone mineral density (BMD) remains unclear. In this study, the proximal femur of 104 men who underwent pelvic MRI and bone densitometry prior to treatment for non-metastatic prostate cancer was retrospectively examined to investigate the R2* value to quantify iron and proton density fat fraction (PDFF) to assess bone marrow fat content. R2* was significantly positively correlated with BMD (r = 0.6017, p < 0.0001), and PDFF was not correlated with BMD (r = −0.1302, p = 0.0512). Patients with BMD T-score ≤ −2.5 had significantly lower R2* than patients with BMD T-score > −2.5; however, there was no significant difference in PDFF. In the ROC analysis, which examined the predictive ability of R2* with BMD T-score ≤ −2.5 as an outcome, the cut-off value of R2* was 50.7 s−1 (AUC 0.817). These results show R2* correlated with BMD. R2* may be a non-invasive surrogate marker for diagnosing male osteoporosis.